Kang S - Search Results

1

Prognostic significance of high metabolic activity in breast cancer: PET signature in breast cancer.

Kang S, Kim EH, Hwang JE, Shin JH, Jeong YS, Yim SY, Joo EW, Eun YG, Lee DJ, Sohn BH, Lee SH, Lim B, Lee JS. Kang S, et al. Biochem Biophys Res Commun. 2019 Mar 26;511(1):185-191. doi: 10.1016/j.bbrc.2019.02.035. Epub 2019 Feb 15. Biochem Biophys Res Commun. 2019. PMID: 30777332 Free PMC article.

2

Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.

Yim SY, Shim JJ, Shin JH, Jeong YS, Kang SH, Kim SB, Eun YG, Lee DJ, Conner EA, Factor VM, Moore DD, Johnson RL, Thorgeirsson SS, Lee JS. Yim SY, et al. Among authors: kang sh. Mol Cancer Res. 2018 Nov;16(11):1713-1723. doi: 10.1158/1541-7786.MCR-18-0313. Epub 2018 Aug 6. Mol Cancer Res. 2018. PMID: 30082483 Free PMC article.

3

Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.

Lee DJ, Eun YG, Rho YS, Kim EH, Yim SY, Kang SH, Sohn BH, Kwon GH, Lee JS. Lee DJ, et al. Oral Oncol. 2018 Oct;85:44-51. doi: 10.1016/j.oraloncology.2018.08.009. Epub 2018 Aug 23. Oral Oncol. 2018. PMID: 30220319

4

Identification of prognostic biomarker in predicting hepatocarcinogenesis from cirrhotic liver using protein and gene signatures.

Yim SY, Hae NJ, Shin JH, Jeong YS, Kang SH, Park YN, Um SH, Lee JS. Yim SY, et al. Exp Mol Pathol. 2019 Dec;111:104319. doi: 10.1016/j.yexmp.2019.104319. Epub 2019 Oct 30. Exp Mol Pathol. 2019. PMID: 31676327

5

Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma.

Yim SY, Kang SH, Shin JH, Jeong YS, Sohn BH, Um SH, Lee JS. Yim SY, et al. Cells. 2020 Sep 1;9(9):2002. doi: 10.3390/cells9092002. Cells. 2020. PMID: 32878261 Free PMC article.

6

Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.

Lee SH, Yim SY, Jeong YS, Li QX, Kang SH, Sohn BH, Kumar SV, Shin JH, Choi YR, Shim JJ, Kim H, Kim JH, Kim S, Guo S, Johnson RL, Kaseb A, Kang KJ, Chun YS, Jang HJ, Lee BG, Woo HG, Ha MJ, Akbani R, Roberts LR, Wheeler DA, Lee JS. Lee SH, et al. Among authors: kang sh, kang kj. Hepatology. 2022 Dec;76(6):1634-1648. doi: 10.1002/hep.32490. Epub 2022 Jun 29. Hepatology. 2022. PMID: 35349735 Free PMC article.

7

Clinically conserved genomic subtypes of gastric adenocarcinoma.

Jeong YS, Eun YG, Lee SH, Kang SH, Yim SY, Kim EH, Noh JK, Sohn BH, Woo SR, Kong M, Nam DH, Jang HJ, Lee HS, Song S, Oh SC, Lee J, Ajani JA, Lee JS. Jeong YS, et al. Among authors: kang sh. Mol Cancer. 2023 Sep 6;22(1):147. doi: 10.1186/s12943-023-01796-w. Mol Cancer. 2023. PMID: 37674200 Free PMC article.

8

The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors.

Kang S, Na Y, Joung SY, Lee SI, Oh SC, Min BW. Kang S, et al. Medicine (Baltimore). 2018 Mar;97(9):e0019. doi: 10.1097/MD.0000000000010019. Medicine (Baltimore). 2018. PMID: 29489646 Free PMC article.

9

RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls.

Kim N, Gim JA, Lee BJ, Choi BI, Park SB, Yoon HS, Kang SH, Kim SH, Joo MK, Park JJ, Kim C, Kim HK. Kim N, et al. Funct Integr Genomics. 2021 Jul;21(3-4):513-521. doi: 10.1007/s10142-021-00795-8. Epub 2021 Jul 17. Funct Integr Genomics. 2021. PMID: 34273035

10

RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.

Kim BR, Kang MH, Kim JL, Na YJ, Park SH, Lee SI, Kang S, Joung SY, Lee SY, Lee DH, Min BW, Oh SC. Kim BR, et al. Among authors: kang mh, kang s. Oncol Rep. 2016 Nov;36(5):2601-2608. doi: 10.3892/or.2016.5086. Epub 2016 Sep 12. Oncol Rep. 2016. PMID: 27633042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,920 results

Search Page